English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
A new era in wearable tech is being etched directly onto the eye.
Dubai-based deeptech startup Xpanceo has raised $250 million in Series A funding to build what it claims is the world’s first multifunctional smart contact lens. The lens aims to merge augmented reality, health monitoring, and advanced optics—like night vision and zoom—into a featherlight device thinner than a human hair. With 15 functional prototypes already built, Xpanceo says it’s on track for clinical trials by 2026.
The lens is packed with innovations: intraocular pressure sensors for non-invasive glaucoma monitoring, biochemical sensors that scan tear fluid for glucose, hormones, and vitamins, and integrated nanophotonic microdisplays that project AR directly onto the retina. It uses just 1–3 microwatts of power—making it hundreds of times more efficient than current AR headsets.
Additional breakthroughs include wireless power transfer, real-time data transmission, color-blindness correction, and nanoparticle engineering for enhanced low-light vision. These modular capabilities could eventually adapt to specialized needs across healthcare, defense, industrial, and consumer sectors.
Xpanceo's long-term vision is bold: replace smartphones, glasses, and even smartwatches with a single, invisible computing interface. Founders Roman Axelrod and Dr. Valentyn Volkov have doubled their team to 100 researchers, filed over 110 scientific publications, and built partnerships with global institutions. The company has also debuted its lenses at trade shows like MWC and GITEX, where it showcased wireless-charging designs and real-time biosensing.
While challenges like FDA approval and miniaturization loom large, investors believe Xpanceo is leading the charge into the post-smartphone age. “They’re not just building a product,” said lead investor Opportunity Venture, “they’re rewriting the rules of personal tech.”
Dubai-based deeptech startup Xpanceo has raised $250 million in Series A funding to build what it claims is the world’s first multifunctional smart contact lens. The lens aims to merge augmented reality, health monitoring, and advanced optics—like night vision and zoom—into a featherlight device thinner than a human hair. With 15 functional prototypes already built, Xpanceo says it’s on track for clinical trials by 2026.
The lens is packed with innovations: intraocular pressure sensors for non-invasive glaucoma monitoring, biochemical sensors that scan tear fluid for glucose, hormones, and vitamins, and integrated nanophotonic microdisplays that project AR directly onto the retina. It uses just 1–3 microwatts of power—making it hundreds of times more efficient than current AR headsets.
Additional breakthroughs include wireless power transfer, real-time data transmission, color-blindness correction, and nanoparticle engineering for enhanced low-light vision. These modular capabilities could eventually adapt to specialized needs across healthcare, defense, industrial, and consumer sectors.
Xpanceo's long-term vision is bold: replace smartphones, glasses, and even smartwatches with a single, invisible computing interface. Founders Roman Axelrod and Dr. Valentyn Volkov have doubled their team to 100 researchers, filed over 110 scientific publications, and built partnerships with global institutions. The company has also debuted its lenses at trade shows like MWC and GITEX, where it showcased wireless-charging designs and real-time biosensing.
While challenges like FDA approval and miniaturization loom large, investors believe Xpanceo is leading the charge into the post-smartphone age. “They’re not just building a product,” said lead investor Opportunity Venture, “they’re rewriting the rules of personal tech.”
A new era in wearable tech is being etched directly onto the eye.
Dubai-based deeptech startup Xpanceo has raised $250 million in Series A funding to build what it claims is the world’s first multifunctional smart contact lens. The lens aims to merge augmented reality, health monitoring, and advanced optics—like night vision and zoom—into a featherlight device thinner than a human hair. With 15 functional prototypes already built, Xpanceo says it’s on track for clinical trials by 2026.
The lens is packed with innovations: intraocular pressure sensors for non-invasive glaucoma monitoring, biochemical sensors that scan tear fluid for glucose, hormones, and vitamins, and integrated nanophotonic microdisplays that project AR directly onto the retina. It uses just 1–3 microwatts of power—making it hundreds of times more efficient than current AR headsets.
Additional breakthroughs include wireless power transfer, real-time data transmission, color-blindness correction, and nanoparticle engineering for enhanced low-light vision. These modular capabilities could eventually adapt to specialized needs across healthcare, defense, industrial, and consumer sectors.
Xpanceo's long-term vision is bold: replace smartphones, glasses, and even smartwatches with a single, invisible computing interface. Founders Roman Axelrod and Dr. Valentyn Volkov have doubled their team to 100 researchers, filed over 110 scientific publications, and built partnerships with global institutions. The company has also debuted its lenses at trade shows like MWC and GITEX, where it showcased wireless-charging designs and real-time biosensing.
While challenges like FDA approval and miniaturization loom large, investors believe Xpanceo is leading the charge into the post-smartphone age. “They’re not just building a product,” said lead investor Opportunity Venture, “they’re rewriting the rules of personal tech.”
·88 Views
·0 Προεπισκόπηση
